Biotangents

About:

Biotangents develop pen-side diagnostic devices to detect infectious diseases in livestock quickly.

Website: https://www.biotangents.co.uk/

Top Investors: Innovate UK, Scottish Enterprise, Kelvin Capital, Scottish Investment Bank

Description:

Biotangents was founded upon their Leapfrog Assembly™ platform technology for building complex genetic constructs from multiple DNA parts. This was developed through a SMART: Scotland award from Scottish Enterprise and was exe0mplified through the generation of their terpenoid biosynthesis strains. During that successful first year they also developed their DNA randomisation technology, Short Sequence Randomisation™. In 2016, having formulated a concept for a modular cell-free nucleic acid detection technology, Moduleic Sensing™, and with support from SynbiCITE, they commenced development of their first diagnostic test, a highly specific and sensitive solution for pen-side diagnosis of infectious diseases in livestock.

Total Funding Amount:

5.4M GBP

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Penicuik, Midlothian, United Kingdom

Founded Date:

2015-01-01

Contact Email:

info(AT)biotangents.co.uk

Founders:

Andrew Hall-Ponselè, Lina Gasiūnaitė

Number of Employees:

1-10

Last Funding Date:

2022-05-18

IPO Status:

Private

Industries:

© 2025 bioDAO.ai